Advanced retinoblastoma treatment: Targeting hypoxia by inhibition of the mammalian target of rapamycin (mTOR) in LHBETATAG retinal tumors

Y. Piña, C. Decatur, T. G. Murray, S. K. Houston, D. Gologorsky, M. Cavalcante, L. Cavalcante, E. Hernandez, M. Celdran, W. Feuer, T. Lampidis

Research output: Contribution to journalArticle

14 Scopus citations

Fingerprint Dive into the research topics of 'Advanced retinoblastoma treatment: Targeting hypoxia by inhibition of the mammalian target of rapamycin (mTOR) in LH<sub>BETA</sub>T<sub>AG</sub> retinal tumors'. Together they form a unique fingerprint.

Medicine & Life Sciences